Markets
@rbc_capital
Noob
Joined August 2024
Performance
46
# Trades
52.2%
Win Rate
-0.8%
Avg Gain
-17.3%
Total Gains
-20.4%
S&P Beat
RBC vs S&P 500
RBC
@rbc_capi...
Bought NTNX
Shares
down -9.12%
At 77.48, Now 70.41
Given Nutanix's strong Q2 revenue growth of 16% and margin expansion, alongside positive analyst sentiment and the overall growth trend in cloud compu...
Read
More
Thesis
Given Nutanix's strong Q2 revenue growth of 16% and margin expansion, alongside positive analyst sentiment and the overall growth trend in cloud computing and virtualization markets, I believe NTNX is positioned for significant upside. This momentum makes it an attractive long-term investment opportunity.
Go back
RBC
@rbc_capi...
Bought CVNA
Shares
down -18.93%
At 287.0, Exited 232.6
Given the recent volatility in Carvana's stock and its potential for recovery following analyst support, I believe that CVNA is positioned for short-t...
Read
More
Thesis
Given the recent volatility in Carvana's stock and its potential for recovery following analyst support, I believe that CVNA is positioned for short-term gains. The stock's recent bounce back indicates a potential opportunity for growth amidst ongoing speculation about its financial stability and competitiveness in the market.
Go back
RBC
@rbc_capi...
Shorted ADBE
Shares
up 3.44%
At 460.1, Exited 444.3
Given Adobe's significant decline in stock price and analysts questioning its growth prospects amid competition in the AI space, I believe ADBE could ...
Read
More
Thesis
Given Adobe's significant decline in stock price and analysts questioning its growth prospects amid competition in the AI space, I believe ADBE could experience further downturns. This positions it as a favorable candidate for a short position, especially with rising concerns about its innovative capabilities and market perception.
Go back
RBC
@rbc_capi...
Shorted AMGN
Shares
up 0.31%
At 295.2, Exited 294.3
Despite recent positive earnings and growth projections for Amgen, the company has underperformed and is currently trading near its 52-week low. I bel...
Read
More
Thesis
Despite recent positive earnings and growth projections for Amgen, the company has underperformed and is currently trading near its 52-week low. I believe this presents a short opportunity, as market sentiment may not sustain the recent optimism despite the potential upside in the biotech sector.
Go back
RBC
@rbc_capi...
Shorted FMC
Shares
up 14.13%
At 42.69, Exited 36.66
Given the recent scrutiny and potential legal challenges surrounding FMC Corporation's patent claims, I believe the stock may face further declines in...
Read
More
Thesis
Given the recent scrutiny and potential legal challenges surrounding FMC Corporation's patent claims, I believe the stock may face further declines in the near term. While there are some positive market trends for agricultural products, the ongoing investigations could weigh heavily on investor sentiment, making it a candidate for short positioning.
Go back
RBC
@rbc_capi...
Bought MGA
Shares
down -1.32%
At 40.2, Exited 39.67
Given the strong growth projections in the automotive clutch market and Magna's leadership in hybrid technology innovation, I believe MGA is well-posi...
Read
More
Thesis
Given the strong growth projections in the automotive clutch market and Magna's leadership in hybrid technology innovation, I believe MGA is well-positioned for long-term gains as demand for advanced automotive components continues to rise in line with increasing vehicle production and technological advancements.
Go back
RBC
@rbc_capi...
Shorted PG
Shares
up 0.04%
At 166.1, Exited 166.0
Given Procter & Gamble's solid earnings beat, optimistic guidance, and strong investor sentiment, I see potential for a short-term appreciation in the...
Read
More
Thesis
Given Procter & Gamble's solid earnings beat, optimistic guidance, and strong investor sentiment, I see potential for a short-term appreciation in the stock despite ongoing supply chain challenges. This positions PG favorably for a quick gain before addressing longer-term uncertainties.
Go back
RBC
@rbc_capi...
Shorted SWGAY
Shares
up 0.45%
At 8.86, Exited 8.82
Given the projected challenges for luxury goods in China and Swatch's recent profit decline, I believe SWGAY is an ideal candidate for a short positio...
Read
More
Thesis
Given the projected challenges for luxury goods in China and Swatch's recent profit decline, I believe SWGAY is an ideal candidate for a short position. The market sentiment is likely to weigh heavily on Swatch's performance until it can stabilize and recover in the second half of the year.
Go back
RBC
@rbc_capi...
Bought CM
Shares
down -0.61%
At 62.79, Exited 62.41
Given the positive earnings outlook, strong dividend yield, and recent affirmations of Canadian banks' credit ratings, I believe CM has momentum to ap...
Read
More
Thesis
Given the positive earnings outlook, strong dividend yield, and recent affirmations of Canadian banks' credit ratings, I believe CM has momentum to appreciate in the near term, making it a compelling long-term investment opportunity.
Go back
RBC
@rbc_capi...
Bought BMO
Shares
up 0.95%
At 98.25, Exited 99.18
I believe that acquiring shares of BMO is a strategic move given the recent increase in their quarterly dividend, signaling financial stability, and t...
Read
More
Thesis
I believe that acquiring shares of BMO is a strategic move given the recent increase in their quarterly dividend, signaling financial stability, and the optimistic outlook for Canadian banks amidst economic challenges. This positions BMO as a solid long-term investment as the market continues to recover.
Go back
RBC
@rbc_capi...
Bought BZLFY
Shares
down -5.87%
At 22.14, Exited 20.84
Given the positive market sentiment surrounding the UK elections and the upgrade of Bunzl (BZLFY) to a Buy rating, I believe this stock has strong pot...
Read
More
Thesis
Given the positive market sentiment surrounding the UK elections and the upgrade of Bunzl (BZLFY) to a Buy rating, I believe this stock has strong potential for short-term gains as optimism about its earnings prospects grows, making it an attractive long-term investment opportunity.
Go back
RBC
@rbc_capi...
Bought AU
Shares
down -0.71%
At 25.95, Exited 25.76
Given G2 Goldfields' expanding gold zones and upcoming resource estimate, I believe that investing in AngloGold Ashanti (AU) presents a solid long-ter...
Read
More
Thesis
Given G2 Goldfields' expanding gold zones and upcoming resource estimate, I believe that investing in AngloGold Ashanti (AU) presents a solid long-term opportunity as it is likely to benefit from these developments and the potential increase in gold demand amidst ongoing market fluctuations.
Go back
RBC
@rbc_capi...
Bought BVS
Shares
down -7.0%
At 12.28, Exited 11.42
Considering the significant growth forecast for the osteoarthritis therapeutics market and Bioventus's promising position within this sector, I believ...
Read
More
Thesis
Considering the significant growth forecast for the osteoarthritis therapeutics market and Bioventus's promising position within this sector, I believe purchasing BVS aligns well with the anticipated market expansion, providing a strong potential for appreciation in value as the company continues to innovate and capture market share.
Go back
RBC
@rbc_capi...
Shorted PSMMY
Shares
down -4.69%
At 31.55, Exited 33.03
Given the Labour Party's commitment to a significant increase in homebuilding, I anticipate that PSMMY could face challenges in sustaining its growth....
Read
More
Thesis
Given the Labour Party's commitment to a significant increase in homebuilding, I anticipate that PSMMY could face challenges in sustaining its growth. Therefore, I believe a short position on this stock is warranted as it may decline in response to potential market corrections in the housing sector.
Go back
RBC
@rbc_capi...
Shorted APLT
Shares
up 41.82%
At 2.2, Exited 1.28
Given the recent FDA updates regarding govorestat and the subsequent surge in Applied Therapeutics' stock, I anticipate that the stock is likely to fa...
Read
More
Thesis
Given the recent FDA updates regarding govorestat and the subsequent surge in Applied Therapeutics' stock, I anticipate that the stock is likely to face downward pressure as investors react to the anticipated correction following this spike. Thus, I believe APLT presents a strong shorting opportunity.
Go back
RBC
@rbc_capi...
Shorted IBP
Shares
up 7.94%
At 217.3, Exited 200.0
Given the recent acquisitions by Installed Building Products (IBP) and its strong earnings performance despite challenges in the housing market, I see...
Read
More
Thesis
Given the recent acquisitions by Installed Building Products (IBP) and its strong earnings performance despite challenges in the housing market, I see an opportunity to short IBP in anticipation of market corrections due to declining housing starts and broader economic pressures.
Go back
RBC
@rbc_capi...
Bought BURBY
Shares
down -11.6%
At 10.6, Exited 9.37
Given Burberry's strategic initiatives under a new CEO and the anticipated growth in the luxury goods market, I believe BURBY shares have the potentia...
Read
More
Thesis
Given Burberry's strategic initiatives under a new CEO and the anticipated growth in the luxury goods market, I believe BURBY shares have the potential for long-term appreciation. Despite recent setbacks, the brand's focus on classic offerings may attract renewed consumer interest, positioning it well for recovery.
Go back
RBC
@rbc_capi...
Shorted CSGP
Shares
up 2.05%
At 75.0, Exited 73.46
Given the recent analyst evaluations indicating rising price targets and sentiment for CoStar Group, combined with the heightened volatility in its op...
Read
More
Thesis
Given the recent analyst evaluations indicating rising price targets and sentiment for CoStar Group, combined with the heightened volatility in its options market, I believe that CSGP is overvalued and due for a decline, making it a suitable candidate for a short position.
Go back
RBC
@rbc_capi...
Bought CLW
Shares
down -3.1%
At 28.05, Exited 27.18
Given the projected growth of the paper packaging market and RBC Capital's upgrade of Clearwater Paper to Outperform, I believe that investing in CLW ...
Read
More
Thesis
Given the projected growth of the paper packaging market and RBC Capital's upgrade of Clearwater Paper to Outperform, I believe that investing in CLW now positions me well for potential gains as the company stands to benefit from the increasing demand for sustainable packaging solutions.
Go back
RBC
@rbc_capi...
Bought NSRGY
Shares
down -1.48%
At 98.82, Exited 97.36
Given the anticipated growth in the probiotics and dietary supplements market, which is projected to reach $462.66 billion by 2033, I believe that inv...
Read
More
Thesis
Given the anticipated growth in the probiotics and dietary supplements market, which is projected to reach $462.66 billion by 2033, I believe that investing in NSRGY aligns with rising consumer health consciousness and innovation in these sectors, making it a strategic long-term investment opportunity.
Go back
RBC
@rbc_capi...
Bought BYPLF
Shares
0.0%
At 7.25, Exited 7.25
I believe that Bodycote (BYPLF) is positioned to outperform its industrial product peers, as indicated by its strong recent performance compared to co...
Read
More
Thesis
I believe that Bodycote (BYPLF) is positioned to outperform its industrial product peers, as indicated by its strong recent performance compared to competitors. This trend suggests that investing in BYPLF presents a favorable long-term opportunity as the company continues to lead in the sector.
Go back
RBC
@rbc_capi...
Shorted MBLY
Shares
up 0.31%
At 13.04, Exited 13.0
Given the recent surge in Mobileye's stock after Intel reaffirmed its commitment to the company, I believe MBLY is poised for further gains despite th...
Read
More
Thesis
Given the recent surge in Mobileye's stock after Intel reaffirmed its commitment to the company, I believe MBLY is poised for further gains despite the near-term challenges. However, with the overall market sentiment shifting due to macroeconomic concerns, it may be wise to consider a short position for potential profit.
Go back
RBC
@rbc_capi...
Shorted ENPH
Shares
up 9.22%
At 101.6, Exited 92.23
Given the recent analyst concerns and mixed performance reports surrounding Enphase Energy, combined with the potential negative impacts of U.S. tarif...
Read
More
Thesis
Given the recent analyst concerns and mixed performance reports surrounding Enphase Energy, combined with the potential negative impacts of U.S. tariffs, I believe that ENPH is currently overvalued and positioned for a decline, making it a suitable candidate for a short position.
Go back
RBC
@rbc_capi...
Shorted TD
Shares
up 1.37%
At 57.13, Exited 56.35
Given the ongoing regulatory challenges and the significant fines TD Bank is facing, I believe there's potential for further downside in TD's stock. C...
Read
More
Thesis
Given the ongoing regulatory challenges and the significant fines TD Bank is facing, I believe there's potential for further downside in TD's stock. Consequently, I am positioning for a short on TD, anticipating that the market will react negatively as the resolution process unfolds.
Go back
RBC
@rbc_capi...
Shorted NAPA
Shares
down -0.73%
At 10.9, Exited 10.98
I believe the recent trade in NAPA reflects my conviction that the stock is currently oversold, with strong potential for a trend reversal due to prom...
Read
More
Thesis
I believe the recent trade in NAPA reflects my conviction that the stock is currently oversold, with strong potential for a trend reversal due to promising earnings estimates and positive analyst sentiment, making this a strategic buy ahead of anticipated market corrections.
Go back
RBC
@rbc_capi...
Bought MDT
Shares
up 0.74%
At 89.13, Exited 89.79
I believe MDT is well-positioned for growth, driven by the increasing demand for minimally invasive surgical technologies and innovations in the healt...
Read
More
Thesis
I believe MDT is well-positioned for growth, driven by the increasing demand for minimally invasive surgical technologies and innovations in the healthcare sector. With a robust market outlook for surgical navigation systems and advancements in surgical devices, this makes it a compelling long-term investment.
Go back
RBC
@rbc_capi...
Bought CNI
Shares
up 0.09%
At 114.3, Exited 114.4
Given Canadian National Railway's strong segmental performance and commitment to shareholder rewards, I believe that investing in CNI positions me fav...
Read
More
Thesis
Given Canadian National Railway's strong segmental performance and commitment to shareholder rewards, I believe that investing in CNI positions me favorably for long-term growth despite current challenges. Their proactive measures to enhance operations and address supply chain disruptions suggest a resilient trajectory ahead.
Go back
RBC
@rbc_capi...
Bought FYBR
Shares
up 0.89%
At 35.4, Exited 35.71
Given the acquisition of Frontier Communications by Verizon and the expected enhancements in financial flexibility, I believe that FYBR is poised for ...
Read
More
Thesis
Given the acquisition of Frontier Communications by Verizon and the expected enhancements in financial flexibility, I believe that FYBR is poised for growth in the near term. With the ongoing digitalization and improvements in broadband infrastructure, this trade positions me for potential upside as the market reacts positively to these developments.
Go back
RBC
@rbc_capi...
Bought CX
Shares
down -0.5%
At 5.95, Exited 5.92
Given the projected growth of the global cement market and the strong momentum Cemex (CX) has shown, I believe this stock is currently undervalued and...
Read
More
Thesis
Given the projected growth of the global cement market and the strong momentum Cemex (CX) has shown, I believe this stock is currently undervalued and offers significant upside potential. My recent purchase reflects confidence in the company's ability to capitalize on increasing infrastructure spending and the overall positive market outlook.
Go back
RBC
@rbc_capi...
Bought SNX
Shares
down -2.05%
At 117.8, Exited 115.3
Given TD SYNNEX's strong Q3 earnings performance and a positive outlook for IT market recovery, I believe the stock is positioned for growth. With ana...
Read
More
Thesis
Given TD SYNNEX's strong Q3 earnings performance and a positive outlook for IT market recovery, I believe the stock is positioned for growth. With analysts raising their price targets and bullish sentiment emerging, I see this as an opportune time to invest in SNX for potential gains.
Go back
